Monday, June 29, 2009

lantus insulin

Sanofi Drug Cancer Risk Should Be Studied, Group Says
"We believe people are entitled to know that use of Lantus insulin might be associated with greater risk, but this must also be balanced against the ...
Insulin taken by 500000 could up cancer risk
Patients taking the long-acting analogue insulin glargine, sold by Sanofi-Aventis under the name Lantus could have a higher risk of developing cancer than ...

Source :

Posted Under : sanofi aventis lantus, lantus, insulin lantus, analoginsulin, lantus krebs

No comments:

Post a Comment


Copyright 2008 All Rights Reserved Revolution Two Church theme by Brian Gardner Converted into Blogger Template by Bloganol dot com | Brought2You by Magazine Template